Roche has launched the Liver Disease Panel, a suite of certified algorithms aimed at improving the management of chronic liver disease (CLD). This panel includes the LiverPRO algorithm, which facilitates early detection of liver fibrosis using routine blood markers.

ClinicalJune 11, 2026

Trial of CXD and Ketogenic Diet for MASLD Shows Structured Approach

A clinical trial is underway to evaluate the efficacy of CXD combined with a restrictive ketogenic diet in treating MASLD.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

Chronic Liver Disease →

Liver Fibrosis →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.